Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Sample Size for Enriched Biomarker Designs With Measurement Error for Time‐to‐Event Outcomes

Pharmaceutical Statistics(2025)10.1002/pst.70027Source: DataRank Database

Sample Size for Enriched Biomarker Designs With Measurement Error for Time‐to‐Event Outcomes is a research paper published in Pharmaceutical Statistics (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (12 grants)Impact (FWCI 0.00)OA: bronzeTopics (31)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Susan Halabi ORCID,Aiyi Liu ORCID,Siyuan Guo ORCID

Live enrichment

PubMed:40711765 PMC:PMC12683776 OpenAlex:https://openalex.org/W4412654834

U.S. Army Medical Research and Materiel Command

Grant: HT9425‐23‐1‐0393

Food and Drug Administration

Grant: 1U01FD007857‐01

NCI NIH HHS

Grant: 5R01-LM013352-03

NCI NIH HHS

Grant: R01CA249279

Medical Research and Materiel Command

Grant: HT9425-23-1-0393

NCI NIH HHS

Grant: R21 CA263950

NCI NIH HHS

Grant: 1R21CA263950-01A1

NCI NIH HHS

Grant: R01CA256157

FDA HHS

Grant: 1U01FD007857-01

FDA HHS

Grant: U01 FD007857

NLM NIH HHS

Grant: R01 LM013352

Prostate Cancer Foundation Challenge Award

FWCI

0.00

Citation Percentile

0.2%

bronzeLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pst.70027

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pst.70027

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/pst.70027

journalhttps://doi.org/10.1002/pst.70027

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40711765

Fields of Study

Statistical Methods in Clinical TrialsCancer Genomics and DiagnosticsPARP inhibition in cancer therapyMedicine

MeSH Terms

HumansMaleProstatic NeoplasmsResearch DesignBiomarkers, TumorBiomarkersRandomized Controlled Trials as TopicClinical Trials, Phase III as TopicSample SizePrecision Medicine

Keywords

StatisticsEvent (particle physics)Sample size determinationSample (material)Computer scienceBiomarkerEconometricsReliability engineeringMathematicsEngineeringBiologyChromatographyChemistryPrevalenceSample sizeBiomarker MisclassificationEnriched Design